Blockchain Registration Transaction Record

Diabetes Drug Plus Healthy Habits Slash Heart Risk by 50%

New study shows combining GLP-1 diabetes medications with healthy lifestyle habits reduces cardiovascular risk by 50% in people with Type 2 diabetes. Learn about the powerful synergy.

This research matters because it provides crucial guidance for the millions of people living with Type 2 diabetes who face significantly elevated cardiovascular risks. With diabetes rates more than doubling in the past two decades and cardiovascular disease remaining the leading cause of death among diabetics, this study offers a clear path to substantially reduce heart attack and stroke risk. The findings are particularly relevant given the growing popularity of GLP-1 medications like Ozempic and Wegovy, showing that while these drugs provide benefits, their effectiveness multiplies when combined with lifestyle changes. For healthcare providers and patients alike, this study reinforces that medication and lifestyle aren't competing approaches but complementary strategies that together offer the strongest protection against life-threatening cardiovascular events.